Atlas Trials

An Observational Study of Tarceva (Erlotinib) in Routine Practice For First Line Maintenance Therapy in Patients With Non Small Cell Lung Cancer

Clinical trial NCT01194050 · COMPLETED

Trial details

NCT number
NCT01194050
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Non-Squamous Non-Small Cell Lung Cancer
Start date
2010-06-01
Primary completion
2013-07-01
Enrollment
289

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.